Home/Stocks/Financials

Pacific Horizon Investment Trust PLC

PHI.L·Financials·Market Cap £862m
Rank #218 of 280
Quantitative Model · 280 Stocks Analysed
£11.24
+44.10% YTD
52W: £7.19 - £12.62

Factor Analysis Summary

Editorial assessment generated from Pacific Horizon Investment Trust PLC's live factor scores and sector positioning.

Based on Strategyland's proprietary 7-factor analysis, Pacific Horizon Investment Trust PLC (PHI.L) currently holds an overall rank of #218 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.

Key strengths include valuation (P/E 2.4, dividend yield 0.1%), where it demonstrates compelling valuation metrics, trading at a discount to peer averages on key multiples; solvency (debt/equity 0.0), where it demonstrates a robust solvency position with conservative leverage and strong balance sheet coverage; and market trading, where it demonstrates strong market trading characteristics with favourable volume trends and institutional participation.

Areas requiring attention include liquidity, where thin trading volumes could increase transaction costs and slippage.

Within the Financials sector, Pacific Horizon Investment Trust PLC sits at composite rank #218, trailing the Financials peer average (rank 8). It ranks behind all 6 tracked Financials peers in our model.

Despite its mid-table composite rank of #218, Pacific Horizon Investment Trust PLC shows selective strength — notably in valuation and solvency — suggesting a stock with identifiable merits alongside clear areas for improvement.

Strongest Factors

  • Valuation — Rank 4/280 (top quartile)
  • Solvency — Rank 25/280 (top quartile)
  • Market Trading — Rank 41/280 (top quartile)

Weakest Factors

  • Liquidity — Rank 278/280 (below average)
  • Asset Efficiency — Rank 80/280 (above average)

Score Analysis

Pacific Horizon Investment Trust PLC is ranked #218 out of 280 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

74/280
Average Score
Liquidity
Weak278/280
Valuation
Excellent4/280
Profitability
Excellent42/280
Solvency
Excellent25/280
Asset Efficiency
Good80/280
Mkt Trading
Excellent41/280
Technical
Excellent50/280

1. Liquidity

Score: 278/280

How liquid is PHI and can it meet its short-term obligations?

0/6
liquidity criteria met
–
Quick RatioN/A
Range: N/A
–
Current Ratio0.10x
Range: N/ARank 246/280
–
TTM Operating Cash Flow0.03x
Range: N/ARank 216/280
–
Liquidity Coverage RatioN/A
Range: 100-150
–
Intangible Asset RatioN/A
Range: 10 - 30Rank 193/280
–
Cash-to-Debt Ratio0.04x
Range: N/ARank 233/280

Key Liquidity Metrics

Quick Ratio
N/A
Sector: N/A
Current Ratio
0.10x
Sector: N/A

Overall Liquidity Rank

Rank within universe#278/280
Best (1)Worst (280)

2. Valuation

Score: 4/280

Is PHI undervalued compared to its peers and fair value metrics?

2/7
valuation criteria met
–
FY27e P/EN/A
Range: 8x - 18x
–
FY26e P/EN/A
Range: 8x - 18x
–
FY27e Net Div Yld (%)N/A
Range: 3.0 - 8.0
✗
Div Payout Ratio0.31%
Range: 30 - 55Rank 50/280
–
Current EV/EBITDA2.2x
Range: N/ARank 15/280
✓
Current P/TBV0.89x
Range: 0.8x - 2.0xRank 39/280
✓
Current P/B0.89x
Range: 0.8x - 2.0xRank 48/280

Key Valuation Metrics

TTM P/E
Price-to-Earnings
2.4x
FY26e P/E
Forward estimate
N/A
FY27e P/E
Forward estimate
N/A
Current P/B
Price-to-Book
0.89x
Current P/TBV
Tangible Book Value
0.89x
Current EV/EBITDA
Enterprise Value
2.2x
FY26e EV/EBITDA
Forward estimate
N/A
FY27e EV/EBITDA
Forward estimate
N/A

Dividend

PHI pays a dividend yield of 0.14%.

Current Yield
0.14%
FY27e Net Div Yield
N/A
FY26e Gross DPS
N/A
FY27e Gross DPS
N/A

3. Profitability

Score: 42/280

How profitable is PHI relative to its peers?

0/7
profitability criteria met
✗
TTM Profit Margin97.8%
Range: 15 - 30Rank 7/280
–
T12 FCF Margin0.0%
Range: N/ARank 202/280
–
FY27e RoEN/A
Range: 10 - 16
–
FY26 EPS GrowthN/A
Range: 8 - 15
–
FY27e EPS GrowthN/A
Range: 6 - 12
–
NIMN/A
Range: 1.5 - 3.2
–
Expense RatioN/A
Range: 50 - 65
TTM Profit Margin
97.8%
Current RoCE
49.6%
FY27e RoE
N/A
T12 FCF Margin
0.0%

4. Solvency

Score: 25/280

How strong is PHI's balance sheet and financial position?

0/6
solvency criteria met
✗
Debt/Eqt0.04x
Range: 0.5x - 1.5xRank 31/280
–
Interest Coverage RatioRank 11
Range: N/ARank 11/280
–
Net Leverage RatioN/A
Range: N/A
–
Altman Z-Score (Manufacturing)26.70
Range: N/ARank 28/280
–
Z-Score (Non Manufacturing)Rank 28
Range: N/ARank 28/280
–
CapAdeq Ratio Tier1N/A
Range: 13 - 18

Key Solvency Metrics

Debt/Eqt
0.04x
Net Leverage Ratio
N/A
Interest Coverage
Rank 11
T12 FCF Margin
0.0%

Altman Z-Score

26.70
Safe Zone
01.812.995+

5. Asset Efficiency

Score: 80/280

How efficiently does PHI deploy its assets and intellectual capital?

0/5
asset efficiency criteria met
–
Efficiency RatioN/A
Range: 50 - 70
–
TTM Asset Turnover Ratio0.48x
Range: N/ARank 134/280
–
TTM CAPEX/SalesN/A
Range: 1 - 3
–
Working Capital TurnoverN/A
Range: N/A
–
R&D/Sales FY27eN/A
Range: N/A

Overall Asset Efficiency Rank

Rank within sector peers#80/280
Best (1)Worst (280)

6. Market Trading

Score: 41/280

How liquid and actively traded is PHI?

1/2
market trading criteria met
–
Intraday Sentiment (%)N/A
Range: 40 - 75
–
10D-Avg v/s 3M-Avg Vol90%
Range: N/ARank 50/280
✓
Avg Directional Index 30D15.2
Range: 012 - 45Rank 221/280
–
Parabolic SAR1154.00
Range: N/ARank 81/280
–
Stock Rating RankN/A
Range: N/A
Market Cap
£861,744,375
Enterprise Value
£897,299,375

Trading Volume

7. Technical

Score: 50/280

What do the technical indicators say about PHI?

0/5
technical criteria met
–
CMP v/s 52-WH-10.9%
£12.62£7.19
-10.9%CMP: £11.24
Range: N/ARank 135/280
–
CMP v/s 52-WL56.3%
£12.62£7.19
+56.3%CMP: £11.24
Range: N/ARank 230/280
–
RSI 14D43.4
043.4 - Bearish100
Range: N/ARank 50/280
–
MA50 - MA200Bullish
£10.28+0.84£11.13
Range: N/ARank 55/280
–
MACD Rank-1.97
Golden Cross
MACD: -1.97
Range: N/A

RSI (14 Day)

43.4
Bearish
0 (Oversold)50100 (Overbought)

Moving Averages

50 SMA£11.13
200 SMA£10.28
SignalGolden Cross (Bullish)
MACD-1.97

Risk Metrics

Beta
N/A
3-Yr Std Dev
N/A
5-Yr Std Dev
N/A

Peer Comparison

How does PHI compare to other Financials stocks?

Overall Rank Comparison

Factor Score Comparison

StockRankLiquidityValuationProfitabilitySolvencyMkt TradingTechnical
PHI#218278442254150
MUT.L#3128382456278
RTW.L#51167914569229
BPCR.L#71633456911276
RCP.L#9179262259132
AGT.L#111085755729079
TBCG.L#1429553825712918
Sponsored
Healthcare Discovery Monitor
Live
Healthcare Discovery Monitor
Healthcare Discovery Monitorby StrategyLand

Catch Healthcare Events Before the Market Moves

SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.

10+
Sources
4
Markets
12h
Cycle
50+
Keywords
USUKCNEU
Launch Monitor

Methodology Note

The analysis presented for Pacific Horizon Investment Trust PLC is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.

Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.

This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.

Note: The information provided is not intended as an offer or solicitation for the purchase or sale of any financial instruments but for investor relations purposes only. The aforementioned securities were offered to the public and currently trade on the secondary market at the exchange mentioned above. It is recommended that investors considering investing in any of these notes consult an approved MiFID Financial Advisor prior to investing.